Our study also raised several important questions: (i) permissively elevated hematocrit levels and clinical outcomes in patients with severe dengue, (ii) the beneficial role of hyperoncotic albumin in patients with severe DSS, and (iii) the optimal volumes of colloid and albumin solutions administered to patients with severe DSS. This evidence concerns the gene ALB and dengue disease.